JAZZ PHARMACEUTICALS PLC (JAZZ)
IE00B4Q5ZN47 - Common Stock
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 79.90M | -224.10M | -329.70M | 238.60M | 523.40M | |||
| Depreciation Amortization | 624.20M | 629.50M | 552.50M | 278.30M | 370.10M | |||
| Income Taxes - Deferred | -369.70M | -292.30M | 69.20M | -136.90M | -236.60M | |||
| Change In Working Capital | 224.70M | 283.30M | 175.10M | -85.40M | -150.10M | |||
| Interest Paid | N/A | 270.70M | 138.30M | 42.50M | 43.00M | |||
| Taxes Paid | N/A | 94.70M | 271.20M | 226.80M | 183.60M | |||
| Other non cash items | 707.40M | 875.50M | 311.40M | 605.20M | 269.60M | |||
| OPERATING CASH FLOW | 1.27B | 1.27B | 778.50M | 899.60M | 776.40M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -399.30M | -498.20M | -45.50M | -379.30M | -182.30M | |||
| Other Investing Activity | N/A | 52.00M | -5.17B | -628.40M | 27.00M | |||
| INVESTING CASH FLOW | -589.20M | -446.20M | -5.21B | -1.01B | -155.30M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -31.00M | -582.00M | 3.87B | 591.80M | -33.40M | |||
| Stock Issued/Repurchased | -102.20M | 98.00M | 135.30M | -46.90M | -243.60M | |||
| Other Financing Activity | -52.10M | -45.40M | -35.60M | -16.90M | -16.70M | |||
| FINANCING CASH FLOW | -185.30M | -529.50M | 3.97B | 528.10M | -293.70M | |||
| Exchange Rate Effect | 4.30M | -6.20M | -3.20M | 400.00K | 400.00K | |||
| CHANGE IN CASH | 496.50M | 290.10M | -466.30M | 420.40M | 327.80M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 1.27B | 1.27B | 778.50M | 899.60M | 776.40M | |||
| Capital Expenditure | -399.30M | -498.20M | -45.50M | -379.30M | -182.30M | |||
| FREE CASH FLOW | 867.40M | 773.80M | 733.00M | 520.30M | 594.10M | |||
All data in USD